Scancell Share Discussion Threads

[inanaco] 24/7/2024 09:39

2tyke - 31 May 2024 - 19:31:39 - 9206 of 9867 Scancell - Pot of Gold or POS? - SCLP
Inane,
I may 'yap' but my posts infer the reasons why yourself and others on here are 'bemused' by the share price
'No buys' you say ?
Read my previous post again carefully and you may begin to understand why I haven't followed yourself in rushing in where angels fear to tread.
Just because it's lost well over 50% recently doesn't make it necessarily cheap btw !

I suggest you stick to science....leave markets and 'money' to the likes of me !

[inanaco] 24/7/2024 09:36

2tyke - 10 Jul 2024 - 10:02:50 - 9607 of 9867 Scancell - Pot of Gold or POS? - SCLP
Still thought I'd buy some under 10p...
Up already !



2tyke - 11 Jun 2024 - 11:23:52 - 9343 of 9867 Scancell - Pot of Gold or POS? - SCLP
I think you'll find that 'no shares' has been the way to go for quite a while.
Data? Has all the data the company has released thus far had any positive impact ?
Just to be clear for all you totally inexperienced marketeers.....stock prices are NOT about data.

says it all

go and work for the labour party ... you will rise to the top ..2tyke

[2tyke] 24/7/2024 09:29

I'm actually one of the few massively in profit here inane...
I'm a stock trader...not a parking attendant ..lol

[pharmaboy3] 24/7/2024 09:26

And me,but I trust marcus!

[inanaco] 24/7/2024 09:26

we make money 2tyke ... you don't

[2tyke] 24/7/2024 09:23

Like I always tell you guys ...good news events follow behind the share price ..the share price never follows the news.
Peeps who think this are simply fooled by volatility.

[inanaco] 24/7/2024 09:23

2tyke you forgot to buy ... the only person that does not understand scancell is you

[ruckrover] 24/7/2024 09:21

Sci,You're spot on there!The ones most likely to sell up are the ex faithful happy clappers. Those with are more realistic perspective are less likely to be disappointed.

[inanaco] 24/7/2024 09:21

I suspect a partnership is soon to be announced ...

obvious is Bristol Myers with moditope and scope, if run in the US as well needed to support

not a licence ...

[2tyke] 24/7/2024 09:20

The stock price has risen from around 9p to over 14p in a couple of months.
It simply needed to take a breather to relieve the excess buying pressure.
Traded markets cannot simply rise and rise...doesn't work that way.

[888icb] 24/7/2024 09:10

The sell on news brigade have pushed this down in early trades but at the end of the first hour of trading as the volume reaches 1 million the buys exceed the sells 2/1. The buys above 14p are kicking back in and the rise you would expect on such excellent news should occur as the day progresses.

[inanaco] 24/7/2024 09:08

we have now, a shot on goal at £8 a share by 2026 .... on one product

i thought it would need moditope assistance

but a interim approval would do it on its own

Lindy would not be making waves of this size without continued proof of concept from the current trials

signal

buy more

[markingtime] 24/7/2024 09:03

.....hence the price moving up, despite the bid having been dropped to 13p. I think it will finish up on the day as this continues.

[chilltime] 24/7/2024 09:02

I’m glad to see Sclp remains below the radar of bonkers retail, who thankfully are fully occupied in likely complete disaster companies.

I’m in this one for the long haul, hoping to sell at 5% of the peak price.

The confusion over apparent lack of interest is now put to bed, there is huge interest in what Scancell are achieving.

The 5% below peak point is typically the price market makers offer on a buy out.
They have the patience to wait for the extra 5%.

[inanaco] 24/7/2024 09:02

MT or don't understand the RNS

[markingtime] 24/7/2024 09:00

Absolutely correct for executed trades. Less true for price indications. For example, you could leave a low bid in the market at, say, 13p.....and just run around lifting all the offers at say 13.75, 13.85 etc.I think that is what is going on today (and much of yesterday).

[2tyke] 24/7/2024 08:55

MT,
Sellers get the 'correct' price.
A stock price is always correct by definition...both buyers and sellers agree on the price dealt.

[marcusl2] 24/7/2024 08:52

Scancell Holdings: Melanoma experts help strengthen registration study plan; CEO 'overwhelmed' by ASCO interest

[markingtime] 24/7/2024 08:48

Interesting to see that most of the trades are above the supposed mid-price rather than below. I suspect that the profit-takers think they are getting a good price.

[marcusl2] 24/7/2024 08:38

World beaters.

The expert panel guiding Scancell;










(Prof Georgina Long AO named as world’s top melanoma expert)



(‘World-Class Leader’ in Melanoma Oncology)







Medical oncologist Jedd Wolchok has played a central role in developing and testing the immunotherapy drugs known as checkpoint inhibitors

[2tyke] 24/7/2024 08:25

Another RNS....that should slow the share price down again.

[sci102] 24/7/2024 08:25

The ones selling most likely are members of the cheerleading group, classic🤣9315;🤣ԍ15;

[marcusl2] 24/7/2024 08:19

I totally agree Inan, early conditional approval at stage II, then continue with stage III

[inanaco] 24/7/2024 08:16

"WoW"

that panel is for early approval ...

ATB

[marcusl2] 24/7/2024 08:12

Burble


Commercial enterprises could cover a whole range of different things.

- Biotechnology companies technically could fall outside of pharmaceutical

- Healthcare organisations (especially US for profits) and health insurance companies - if iSCIB1+ is cheaper to produce, administer etc

- Contract research organisations - especially those wanting to support a Ph2/3 trial

- Supply chain - for example people are building supply chains for personalised mRNA med and the iSCIB1+ Ph3 trial could demonstrate that this is unnecessary

- Healthcare consulting firms

- Marketing and advertising firms

- Legal and regulatory firms - think consulting etc.

Then I guess outside of this, we have the wider Immunobody platform to consider. I can imagine this could easily be modified for animal health for instance, or as has been demonstrated has been used for infectious disease - plenty of companies out there who would be interested either from a treating patients angle, or because ImmunoBody could disrupt their markets.